Phenytoin and cyclosporine A specifically regulate macrophage phenotype and expression of platelet-derived growth factor and interleukin-1 in vitro and in vivo: possible molecular mechanism of drug-induced gingival hyperplasia.
about
Phenytoin-induced gingival overgrowthDrug-induced gingival hyperplasia in transplant recipients.Phenytoin and cyclosporin A suppress the expression of MMP-1, TIMP-1, and cathepsin L, but not cathepsin B in cultured gingival fibroblasts.Increased expression of vascular endothelial growth factor in cyclosporin A-induced gingival overgrowth in rats.The role of drugs in the pathogenesis of gingival overgrowth. A collective review of current concepts.Epithelial to mesenchymal transition in gingival overgrowth.Reduction of severe gingival overgrowth in a kidney transplant patient by replacing cyclosporin A with tacrolimus.Molecular and clinical aspects of drug-induced gingival overgrowth.Mechanisms and management of gingival overgrowth in paediatric transplant recipients: a review.Connective tissue metabolism and gingival overgrowth.Impact of phenytoin therapy on the skin and skin disease.Diphenylhydantoin promotes proliferation in the subventricular zone and dentate gyrus.Phenytoin-induced gingival overgrowth: a review of the molecular, immune, and inflammatory features.The possible potential therapeutic targets for drug induced gingival overgrowth.Drugs, medications and periodontal disease.In vivo association of immunophenotyped macrophages expressing CD163 with PDGF-B in gingival overgrowth-induced by three different categories of medicationsRole of nuclear factor kappa-B in phenytoin-induced gingival overgrowth.Immunoexpression of interleukin-6 in drug-induced gingival overgrowth patients.Enhanced Activity of the Macrophage M1/M2 Phenotypes and Phenotypic Switch to M1 in Periodontal Infection.Matrix metalloproteinases (MMP-8 and -9) and neutrophil elastase in gingival crevicular fluid of cyclosporin-treated patients.Regulation of gingival fibroblast interleukin-6 secretion by cyclosporine A.On the Cellular and Molecular Mechanisms of Drug-Induced Gingival Overgrowth.Effect of phenytoin and age on gingival fibroblast enzymes.Suppression of LPS-induced matrix-metalloproteinase responses in macrophages exposed to phenytoin and its metabolite, 5-(p-hydroxyphenyl-), 5-phenylhydantoin.Is periodontal health a predictor of drug-induced gingival overgrowth? A cross-sectional study.Platelet-derived growth factor (PDGF) isoform and PDGF receptor expression in drug-induced gingival overgrowth and hereditary gingival fibrosis.Macrophages and lymphocyte subpopulations in nifedipine- and cyclosporin A-associated human gingival overgrowth.Cyclosporin-induced gingival overgrowth at the newly formed edentulous ridge in rats: a morphological and histometric evaluation.Connective tissue growth factor in drug-induced gingival overgrowth.Cytokine regulation of gingival fibroblast lysyl oxidase, collagen, and elastin.Macrophage subpopulations in gingival overgrowth induced by nifedipine and immunosuppressive medication.The effects of cyclosporin on the collagenolytic activity of gingival fibroblasts.Impaired degradation of matrix collagen in human gingival fibroblasts by the antiepileptic drug phenytoin.Cyclosporin A specifically affects nuclear PLCbeta1 in immunodepressed heart transplant patients with gingival overgrowth.Effect of cyclosporin A on the expression of inducible nitric oxide synthase in the gingiva of rats.Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor gene and protein expression in cyclosporin-induced overgrown edentulous gingiva in rats.Apoptosis and expression of caspase-3 in cyclosporin-induced gingival overgrowth.Mast cells are not involved in the development of cyclosporin A-induced gingival hyperplasia: a study with mast cell-deficient mice.Cyclosporine A inhibits the expression of membrane type-I matrix metalloproteinase in gingiva.Immunohistochemical evaluation of Ki-67 expression and apoptosis in cyclosporin A-induced gingival overgrowth.
P2860
Q28239801-07AEB205-40E5-4176-836A-E8A236C784B6Q30704283-C1C6AFC7-4E61-4ECF-8128-E8F715284DF5Q31417108-5BEC99F0-1A3F-4079-A9C1-FD2C1BE9EF83Q33238284-A33A3189-3C04-44E8-BB4D-A266F6ACD67AQ33768650-E7BBE14E-E991-4958-83A5-99451BD2DFDEQ33947224-9507D618-2FBA-4A6E-B7DC-E41076B63D15Q34076610-AAD8229F-C05F-48F6-A696-461FFCD1616AQ34462674-58F5B136-C367-4510-AC77-5CCBCA81D872Q35166391-9C499B02-715D-474A-A8E8-19512ED90D80Q35798724-AD32B0BC-558D-4263-A5F6-95A3B0FFAFBCQ35925673-E1C0E7CE-89E2-49EF-A37E-82043FA34971Q37518096-DED76703-7BB2-4C37-AE3B-69AA5BB90878Q37944795-C4A9EC42-F6B0-40CE-BB1E-633E01289CAEQ38108291-06F53892-1837-4B41-AF46-56B4A08B44C8Q38262447-AD238631-2EEE-4541-8EB0-BDB46C398498Q38518088-CA3B655C-0804-4319-B19F-06A78C23206FQ39423496-1B7C813F-73A4-4878-8D4E-D09F604F18DAQ39679820-622A096F-FA4B-4449-8DB0-2901C13A23C6Q40675541-11438598-4B46-4F4F-B110-11DE248E9C80Q40710630-264AECE2-A7C5-4386-A205-1D45CE5F883CQ40782502-65EF7A6F-C417-4D75-AF4D-4EDA6BBB8CD5Q41467496-C00C9D45-FB95-414E-9AAD-0FDAA492CC47Q41515803-7BCC5EAB-0FF4-425A-B1A3-8F613A7FF895Q41761895-F838E4BD-1C51-4862-AB03-FB6A76F3CDDAQ41901984-E6EF7EE9-CCED-4806-9CB9-0580365A923CQ42685797-7CD2548A-2EFB-4456-A5F7-5FA42837DA15Q43565920-9E17289F-61FF-432D-BE64-B15EBFA2194BQ43701113-8BE17EBA-DD25-43D8-B876-980A1B7505AEQ43701123-01793D2C-4E56-49B6-AC15-B0ABAED5BCC1Q43918255-A60FE1BE-C6C6-44CD-ABB8-12DBBE77A5D6Q44247075-03DD9929-F670-4E90-8D7E-08E6D7575911Q44441286-01FF4398-E79F-41AD-9E9D-FD3AF35E212FQ46538918-37E0FC5D-D351-426E-8013-5DE94289B878Q46616147-846E1822-15D6-469B-B44F-8BDE06571D8EQ46839064-0B3696FD-4B79-4C24-872C-1BD24D2B9267Q46839065-C0CAD368-5777-4E51-BE60-F414D6BB9105Q46871497-EA4BBA4D-6E2B-45F4-B53F-CE08CFB57AD2Q50509818-15E1218D-BF4A-4817-98D4-509933E8995EQ51827205-389C19EE-79CD-4FA0-AAED-EC847F131281Q53573408-5CC309D6-50F7-44C2-8D76-95E22C8996DF
P2860
Phenytoin and cyclosporine A specifically regulate macrophage phenotype and expression of platelet-derived growth factor and interleukin-1 in vitro and in vivo: possible molecular mechanism of drug-induced gingival hyperplasia.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Phenytoin and cyclosporine A s ...... -induced gingival hyperplasia.
@en
Phenytoin and cyclosporine A s ...... -induced gingival hyperplasia.
@nl
type
label
Phenytoin and cyclosporine A s ...... -induced gingival hyperplasia.
@en
Phenytoin and cyclosporine A s ...... -induced gingival hyperplasia.
@nl
prefLabel
Phenytoin and cyclosporine A s ...... -induced gingival hyperplasia.
@en
Phenytoin and cyclosporine A s ...... -induced gingival hyperplasia.
@nl
P2093
P356
P1476
Phenytoin and cyclosporine A s ...... -induced gingival hyperplasia.
@en
P2093
Gonzales A
Iacopino AM
P356
10.1902/JOP.1997.68.1.73
P407
P577
1997-01-01T00:00:00Z